types of myasthenia gravis
About 85% of people with myasthenia gravis have unusually high levels of acetylcholine receptor antibodies in their blood.
Approximately 6% of people diagnosed have muscle-specific kinase (MuSK) antibodies.
Myasthenia gravis is a treatable condition.
Symptoms range from mild to severe. Symptoms tend to reach their peak in severity within one to three years of initial diagnosis.
It is rare to inherit autoimmune myasthenia gravis. you can inherit congenital myasthenia or neonatal myasthenia.
Types where inheritance happens usually occur in an autosomal recessive pattern where you need two genes one from each biological parent, to experience symptoms.
While MG is commonly discussed as a single condition, it encompasses several distinct types based on the underlying cause, antibody presence, and areas of muscle weakness. Understanding these differences is crucial for accurate diagnosis and tailored treatment.
Here is a breakdown of the various types of Myasthenia Gravis:
Generalized Myasthenia Gravis (gMG)
Generalized Myasthenia Gravis is the most common form of the disease. It involves widespread muscle weakness that can affect the eyes, face, throat, limbs, and respiratory muscles.
Characteristics:
Weakness can impact voluntary muscles, including those used for chewing, speaking, and breathing.
Symptoms often worsen with activity and improve with rest.
Key Antibodies:
Acetylcholine Receptor (AChR) Antibodies: Found in approximately 85% of patients with generalized MG (National Institute of Neurological Disorders and Stroke).
Muscle-Specific Kinase (MuSK) Antibodies: Detected in some cases of generalized MG, particularly in patients negative for AChR antibodies.
Ocular Myasthenia Gravis (oMG)
Ocular Myasthenia Gravis is limited to muscles that control the eyes and eyelids.
Characteristics:
Symptoms include drooping eyelids (ptosis) and double vision (diplopia).
Weakness is restricted to ocular muscles, but about 50% of patients may eventually develop generalized MG.
Key Antibodies:
AChR antibodies are present in some cases.
MuSK and LRP4 antibodies are typically not associated with purely ocular MG.
Seronegative Myasthenia Gravis (SNMG)
Seronegative MG refers to cases where standard antibody tests (AChR and MuSK) are negative. Despite this, patients exhibit clinical symptoms of MG.
Characteristics:
Symptoms can be similar to generalized MG, though diagnosis may require additional tests.
Electrophysiological studies and response to treatment help confirm the diagnosis.
Key Antibodies:
Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) Antibodies have been found in some SNMG patients.
Ongoing research aims to identify other potential autoantibodies in this subset.
Congenital Myasthenic Syndromes (CMS)
Congenital Myasthenic Syndromes are rare, inherited forms of MG caused by genetic mutations rather than an autoimmune response.
Characteristics:
Symptoms often appear in infancy or childhood.
Muscle weakness is due to genetic defects affecting the neuromuscular junction.
Unlike autoimmune MG, CMS does not involve autoantibodies.
Key Difference:
Diagnosed through genetic testing rather than antibody detection.
Juvenile Myasthenia Gravis (JMG)
Juvenile Myasthenia Gravis refers to MG that occurs in children and adolescents, typically before the age of 18.
Characteristics:
Can present as either ocular MG or generalized MG, with symptoms similar to adult-onset MG.
Symptoms may include ptosis, difficulty swallowing, fatigue, and generalized muscle weakness.
Key Antibodies:
AChR antibodies are often present, but some cases may be seronegative.
MuSK antibodies may also be detected in some patients.
Special Considerations:
JMG may respond differently to treatments, and children often require tailored care to manage the condition and its impact on growth and development.
Myasthenia Gravis with Thymoma
Some cases of MG are associated with tumors in the thymus gland, known as thymomas.
Characteristics:
Thymomas are found in 10-15% of MG patients.
Removal of the thymus gland (thymectomy) may improve symptoms, especially in younger patients.
Key Antibodies:
Most patients have AChR antibodies.
MuSK-Positive Myasthenia Gravis
This form of MG is defined by the presence of muscle-specific kinase (MuSK) antibodies.
Characteristics:
Weakness primarily affects bulbar muscles (used for speaking, chewing, and swallowing) as well as neck and respiratory muscles.
Muscle atrophy may occur in severe cases.
Key Facts:
MuSK-MG is less common but can be more severe and resistant to standard treatments.
Understanding the different types of Myasthenia Gravis (MG) is vital for accurate diagnosis and effective treatment. Each subtype has unique characteristics, diagnostic criteria, and treatment considerations. Whether it is identifying specific antibodies or recognizing distinct patterns of muscle weakness, advances in medical research continue to improve outcomes for MG patients. If you or a loved one experience symptoms of MG, consult a Neurologist for proper testing and personalized care.
references and additional reading
REWRITING RARE
Sharing real Myasthenia Gravis stories- one voice at a time
CONTACT US: COntact@rewritingrare.com
JOIN THE COMMUNITY
© 2025. All rights reserved.